Definitive Healthcare Q2 revenue $54.5M (+37% YoY); net loss narrows; raises FY guidance

Definitive Healthcare Corp.

2022-Q2 EPS reported -$0.14 revenue$104,672,000

Revenue $54.5M (+37% YoY); net loss ($9.6M) improved from ($15.0M) in Q2 2021.
Adjusted Net Income $8.9M (vs $2.0M); Adjusted EBITDA $16.3M (30% of revenue).
Enterprise customers (ARR >$100k) reached 486; launched Passport Express and Monocl ExpertInsight 2.0.
Q3 2022 revenue guidance $56-57M; FY 2022 revenue guidance $220.5-224.5M (34% YoY growth midpoint).
Unlevered free cash flow $19.1M in Q2; trailing twelve months $63.4M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.